# Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

> **NCT03180866** · NA · UNKNOWN · sponsor: **Illumicure Inc** · enrollment: 32 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** Luma Light System

## Key facts

- **NCT ID:** NCT03180866
- **Lead sponsor:** Illumicure Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180866, "Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03180866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*